Reduced bladder responses to capsaicin and GSK-1016790A in retired-breeder female rats with diminished volume sensitivity

Am J Physiol Renal Physiol. 2018 Nov 1;315(5):F1217-F1227. doi: 10.1152/ajprenal.00198.2018. Epub 2018 Jul 18.

Abstract

Literature documents an age-related reduction of bladder sensory function. Transient receptor potential vanilloid (TRPV)1 or TRPV4 channels have been implicated in bladder mechanotransduction. To investigate contributions of TRPV1 or TRPV4 to the age-related reduction of bladder sensory function, bladder responses to capsaicin (CAP; TRPV1 agonist) and GSK-1016790A (GSK; TRPV4 agonist) in retired breeder (RB; 12-15 mo) and young adult (2-3 mo) female rats were compared using multiple methods. Metabolic cage and continuous infusion cystometry [cystometrogram (CMG)] recordings revealed that RB rats exhibit larger bladder capacity and lower voiding frequency. RB rats also have a greater intravesical pressure threshold for micturition; however, the voiding contraction strength was equivalent to that in young rats. CAP (1 μM) or GSK (20 nM) administered intravesically evoked smaller changes in all CMG parameters in RB rats. In vitro, CAP (1 μM) or GSK (20 nM) evoked smaller enhancement of bladder strip contractions, while the muscarinic receptor agonist carbachol (at 100, 300, and 1,000 nM) elicited greater amplitude contractions in RB rats. Patch-clamp recording revealed smaller CAP (100 nM) induced inward currents in bladder primary sensory neurons, and Ca2+ imaging revealed smaller GSK (20 nM) evoked increases in intracellular Ca2+ concentration in urothelial cells in RB rats. These results suggest that RB rats have a decreased bladder sensory function commonly observed in elderly women, and could be used as an animal model to study the underling mechanisms. Reduced functional expression of TRPV1 in bladder afferents or reduced functional expression of urothelial TRPV4 may be associated with the diminished sensory function.

Keywords: TRP channels; aging; urinary bladder.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Administration, Intravesical
  • Age Factors
  • Aging
  • Animals
  • Calcium Signaling / drug effects
  • Capsaicin / administration & dosage
  • Capsaicin / pharmacology*
  • Female
  • Leucine / administration & dosage
  • Leucine / analogs & derivatives*
  • Leucine / pharmacology
  • Mechanotransduction, Cellular / drug effects
  • Membrane Potentials / drug effects
  • Muscle Contraction / drug effects
  • Neurons, Afferent / drug effects*
  • Neurons, Afferent / metabolism
  • Rats, Sprague-Dawley
  • Sulfonamides / administration & dosage
  • Sulfonamides / pharmacology*
  • TRPV Cation Channels / agonists*
  • TRPV Cation Channels / metabolism
  • Urinary Bladder / drug effects*
  • Urinary Bladder / innervation
  • Urinary Bladder / metabolism
  • Urination / drug effects*
  • Urodynamics / drug effects*
  • Urothelium / drug effects*
  • Urothelium / metabolism

Substances

  • N-(1-((4-(2-(((2,4-dichlorophenyl)sulfonyl)amino)-3-hydroxypropanoyl)-1-piperazinyl)carbonyl)-3-methylbutyl)-1-benzothiophene-2-carboxamide
  • Sulfonamides
  • TRPV Cation Channels
  • Trpv1 protein, rat
  • Trpv4 protein, rat
  • Leucine
  • Capsaicin